BGT vs REG

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

41LOW

REG

REG HEALTH FPO [REG]

41LOW

Score Breakdown

BGT REG
Technical
46
44
Catalyst
50
57
Sentiment
50
50
Fundamental
44
94
Momentum
42
64
Risk Gate
24
50

Key Metrics

BGT Metric REG
$6.6MMarket Cap$1.9B
607KAvg Volume (20d)863K
N/AShort Interest+1.1%
$0.06152-Week High$9.400
$0.01652-Week Low$5.620
+0.0%Daily Change-1.5%
$0.017Reference Price$6.080
-202.2%ROEN/A
N/AProfit Margin+3.0%

Active Signals

BGT Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.7 quarters)
Strong revenue growth (+208%)

REG Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (1.5x)
Moderate revenue growth (+18%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare BGT and REG in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MVF vs OSL →BGT vs MVF →BGT vs OSL →DXB vs EIQ →EIQ vs MEM →
BGT Full Analysis → REG Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).